ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves New Indications for Zomacton
americanpharmaceuticalreview
July 24, 2018Ferring Pharmaceuticals the U.S. Food and Drug Administration (FDA) has approved Zomacton (somatropin) for injection in four additional pediatric indications: -
Ferring's ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficien
biospace
February 02, 2018?Ferring Pharmaceuticals?today announced thatFDA has approved ZOMACTON??for Injection 5 mg and 10 mg recombinant human growth hormone indicated for replacement of GH in adults with GH deficiency.
Pharma Sources Insight January 2025
